|
|
|
06.11.25 - 07:00
|
DBS Group Q3 Net Profit Declines (AFX)
|
|
|
BRUSSELS/FRANKFURT/PARIS (dpa-AFX) - DBS Group Holdings reported third quarter net profit of S$2.95 billion compared to S$3.03 billion, last year. Reported earnings per share was S$4.12 compared t......
|
|
|
|
|
|
|
06.11.25 - 04:15
|
DBS 3Q NP Sinks 2% YoY; Revenue Sets Record High (AAStocks)
|
|
|
DBS Group announced that its net profit for 3Q25 sank 2% YoY to SGD2.95 billion, under the influence of the global minimum tax rate. Total revenue grew 3% YoY to SGD5.93 billion, notching a record high. PBT increased by 1% YoY to approximately SGD3.48 billion, also hitting a record high.The board declared a 3Q25 DPS totaling 75 ......
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
23.10.25 - 06:18
|
DBS China CEO on Business Strategy (Bloomberg)
|
|
|
Ginger Cheng, China CEO at DBS, discusses the bank's business strategy in the country. She speaks with Stephen Engle from the sidelines of the Bund Summit in Shanghai. (Source: Bloomberg)...
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
21.08.25 - 09:18
|
Qlife together with Birmingham Women′s and Children′s NHS Foundation Trust achieve positive results for its rare disease self-test PHE product (Cision)
|
|
|
Gothenburg, Sweden - Qlife Holding AB (“Qlife” or the “Company”) announces that it has finalized its clinical study for children and young people under 18 years of age. The study was focused on the self-test at-home aspect and the comparison of data to standard of care methodology DBS-cards (Dried Blood Spots). The study and the enrollment were completed under the leadership of Professor Anita MacDonald, Professor in Dietetics at Birmingham Women's and Children's NHS Foundation Trust.
Summary of results:
· High concordance between Egoo PHE Test results and the Dry Blood Spot (DBS)...
|
|
|
21.08.25 - 08:36
|
Qlife together with Birmingham Women′s and Children′s NHS Foundation Trust achieve positive results for its rare disease self-test PHE product (Cision)
|
|
|
Gothenburg, Sweden - Qlife Holding AB (“Qlife” or the “Company”) announces that it has finalized its clinical study for children and young people under 18 years of age. The study was focused on the self-test at-home aspect and the comparison of data to standard of care methodology DBS-cards (Dried Blood Spots). The study and the enrollment were completed under the leadership of Professor Anita MacDonald, Professor in Dietetics at Birmingham Women's and Children's NHS Foundation Trust.
Summary of results:
· High concordance between Egoo PHE Test results and the Dry Blood Spot (DBS)...
|
|
Börsentreff auf Facebook |
Börsentreff auf X |
Börsentreff auf Instagram
